Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DOSCORT: Betamethasone Dose-Response in Addison's Disease
NCT03210545Phase 4Completed
- Sponsor
- University of Gothenburg
- Start
- Mar 2021
- Primary completion
- Nov 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of betamethasone in Addison's disease, sponsored by University of Gothenburg. Started Mar 2021; status: completed.
02
Drugs
betamethasone
03
Conditions
Addison's disease
Beyond the preview
Go deeper on NCT03210545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03210545.